68 results
8-K
EX-99.1
IMVT
Immunovant Inc
12 Feb 24
Results of Operations and Financial Condition
7:02am
with autoimmune diseases. As a trailblazer in anti-FcRn technology, the Company is developing innovative, targeted therapies to meet the complex and variable needs
8-K
EX-99.1
IMVT
Immunovant Inc
20 Dec 23
Immunovant Reports Positive Initial Phase 2 Results for Batoclimab in Graves’ Disease
4:37pm
to enabling normal lives for people with autoimmune diseases. As a trailblazer in anti-FcRn technology, the Company is developing innovative, targeted
8-K
EX-99.1
IMVT
Immunovant Inc
28 Nov 23
Immunovant Announces Positive IMVT-1402 Initial 600 mg MAD Results that Confirm Best-in-Class Potential
7:43am
for people with autoimmune diseases. As a trailblazer in anti-FcRn technology, the Company is developing innovative, targeted therapies to meet
S-3ASR
IMVT
Immunovant Inc
9 Nov 23
Automatic shelf registration
8:49am
lives for people with autoimmune diseases. Our innovative product pipeline includes batoclimab and IMVT-1402, both of which are novel, fully human … for people with autoimmune diseases. Our innovative product pipeline includes batoclimab and IMVT-1402, both of which are novel, fully human monoclonal
8-K
EX-99.1
eqfkh8uq
9 Nov 23
Results of Operations and Financial Condition
7:06am
424B5
a9h51l
29 Sep 23
Prospectus supplement for primary offering
4:48pm
424B5
t18wrc7hfzryv t0gkml
26 Sep 23
Prospectus supplement for primary offering
5:28pm
8-K
EX-99.1
l7dt 0m6rbab
26 Sep 23
Immunovant Announces Positive Initial IMVT-1402 Phase 1 SAD and 300 mg Subcutaneous MAD Results
7:45am
8-K
EX-99.1
rgye4uq
10 Aug 23
Results of Operations and Financial Condition
7:10am
8-K
EX-99.1
eg25uty hisvuxh1
22 May 23
Results of Operations and Financial Condition
7:03am
8-K
EX-99.1
s725m0b 477fl
4 Nov 22
Results of Operations and Financial Condition
7:15am
424B5
ks7x9okxpedbtnmjf5i
5 Oct 22
Prospectus supplement for primary offering
4:43pm
8-K
EX-99.1
7l4sb1 5bj9kx4kjg
28 Sep 22
Immunovant Announces IMVT-1402, a Next Generation Anti-FcRn
10:49am
8-K
EX-99.2
vxaw01cn
7 Sep 22
Regulation FD Disclosure
6:39am